Clinical Impact of Molecular Imaging

Twitter icon
Facebook icon
LinkedIn icon
e-mail icon
Google icon

Clinical Impact of Molecular Imaging

Tuesday, Nov. 30, 10:30 AM - 12:00 PM

Speakers are discussing the clinical and practice implications of the increased use of PET/CT in clinical decision-making and sharing information about opportunities for nuclear medicine technologists in the Clinical Trials Network.

The speakers are:

  • Charles T. Stanley, imaging manager, 3D/CT/MRI lab, University of Virginia in Charlottesville, Va.;
  • David Gilmore, operations manager, imaging and cardiac testing, Massachusetts General Hospital in Boston.